Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Having checked my Selftrade account at 4:30pm I found listed 2 more items which detailed my "basic" and "excess" entitlements under the OO. The conditions of the Offer were not then posted in my message box on the selftrade site, but I have just checked - - and there it is. It seems that the number of "excess" entitlements given is a maximum for which I may apply, but the amount I would get is "subject to availability". Presumably the total "excess" entitlements will come out of the pool of "basic" OO shares which have not been taken up by some. Judging by the general sentiment here, there won't be many left to go into the pool, and so we will be unlikely to be awarded all the "excess" that we would like to buy under this Offer. As of this moment my Hargreaves Lansdown message box shows nothing at all about the Offer.
. We believe that the IONA® Test will be the first regulated CE marked in vitro non-invasive diagnostic pre-natal screening product to market. CE mark is the European Conformity mark - we would be the first to have it.
in summary it is clear the BOD have looked at the market and what is on the market. with a 4.2b market there is always room for more than one provider. name any industry that only has one supplier to the market. every share im in has multi / many suppliers. telecoms / simulation training / oil gas drilling/ the list is endless etc etc.... what did adam reynolds say to sfu ? "THE BEST DEAL IVE EVER DONE"
further from the rns on the same issues The Directors and the Proposed Directors believe that the market potential is significant. There are an estimated 9.5 million births per annum in the USA and Europe and an estimated 140 million births per annum globally. Initially the new tests will be primarily offered to the 20 per cent. of women at high risk of an affected fetus in the developed world with subsequent expansion to lower risk pregnancies and wider geographies. At present the price of the new DNA-based tests is between $800 and $1,800 suggesting a market size of between $4-8 billion in Europe and the USA alone. Over time the price will fall but the number of women taking the test will increase. A recent market report estimated the existing market potential as $1.5 billion growing to $5 billion in 2018 if a reliable cost effective test was available to encourage widespread adoption. It is precisely this market need that the IONA® Test aims to address. Premaitha's diagnostic solution Given the size of the market opportunity and the benefits of the technology for non-invasive pre-natal testing, several companies, principally in the USA, have emerged offering a similar laboratory developed testing service directly to obstetricians and pregnant women. These companies target the final customer for the improved pre-natal tests but the Directors and Proposed Directors believe that the new technology will also cause significant change in the laboratory testing market. A well-established pre-natal Down's Syndrome screening infrastructure is already in existence in Europe. It is estimated that there are currently 600 laboratories performing around 3.5 million Down's Syndrome screens annually in Europe. The Directors and Proposed Directors believe that laboratories providing the existing pre-natal screening assays will need to adopt the new technology or see their business disappear to new providers.
Sorry, should have been second *that Ian, useful posts thankyou
I may be having one of my "thick" moments, but I cannot find the published details of the Open Offer Entitlement. It must be that i am looking in the wrong documents; so can anyone point me in the right direction (by posting a link perhaps) ?
Evening all, just logged on to my share account and there is 125 added share titled "sub shs claims" of vialogy plc new ordinary gbp0.001 any ideas what these are as I've not read anything about them. Cheers
you can see form that comment that he is aware that this approach has been used since 2011 by several screening companies. Im sure adam wil have looked at the market potential of Premaithas product -V- any others available. His track record of making money in companies is awesome. read up on what he did at admiral sports etc.
david look also at adam reynolds comments on the rns... "Premaitha offers us an exciting opportunity to acquire a molecular diagnostics company that has developed a non-invasive pre-natal screening test for Down's Syndrome. The IONA® Test is based on the analysis of fetal DNA in the maternal bloodstream, an approach that has been used since 2011 by several screening companies, principally in the USA. We believe that the IONA® Test will be the first regulated CE marked in vitro non-invasive diagnostic pre-natal screening product to market.
i think raising these links is useful but at the same time confusing and does raise questions as its quite clear premaitha claim on their website that the test they offer is the first of its kind. This term"first" is mentioned in unequivocal terms in more than one page pf the website.. see below.. The IONA® test is the first non-invasive in vitro diagnostic product for prenatal screening. The IONA® test is a complete diagnostic system that is simple and standardised, enabling Premaitha’s clinical laboratory customers to perform the test in their laboratory, using existing clinical workflow. The IONA® test is non-invasive, simple and accurate, and is designed to encourage the broad uptake of the technology allowing all pregnant women accurate and safe information about their pregnancy. Key Features The first non-invasive prenatal IVD product Based on next generation sequencing technology (NGS) 2-3 day turnaround to result Plasma from maternal blood sample CE marked IVD (expected Jan 2015) Typical data shows >99% detection, <1% false positive rate Throughput of ~200 samples/week (with 1x IONA system) Dedicated technical support team be useful if sfu or riddler who have communications with AR could ask the questions you pose.
Part of the evaluation of any company that you're thinking of buying is to try to evaluate its competition. The lack of critical approach displayed by some on here is truly shocking. Any comment which tries to get an objective evaluation is branded as being from a short seller. Many here will have lost a lot of money on Vialogy. They might not have lost so much if they had had a better idea of what software the oil industry was actually investing in. I'm not deramping I'm just doing what you should be doing which is to evaluate what's on offer - that's why I don't have to hide behind a psuedonym. Duh!
How to Order The IONA test will be available as a CE marked product for use in clinical laboratories from January 2015. Premaitha are currently in discussions with laboratory customers and advising them on how to be one of the first clinical laboratories across Europe to offer this test to pregnant women. Please call or email to arrange a visit with our commercial team to discuss the IONA test in further detail. iona@premaitha.com T: +44 (0) 161 667 6865
got me options through just now. bloody struggling to get a few K together tho just my luck.....
seekerforprofit, pablo2 and alphapig for your responses, much appreciated
From Premaitha's website:"The IONA® test is the first non-invasive in vitro diagnostic product for prenatal screening." From Mark Collingbourne CFO Vialogy in response to my email on Premaitha's website asking about competitors: "I am sure you appreciate that the only information we can give out at this time, is that which is in the public domain. I would refer you to our website www.premaitha.com and the admission document which can be downloaded from www.vialogy.com. " Oh, and here's another one: http://www.downsyndromenipt.info/ which makes three companies already offering NIPT for Downs syndrome that I've found. Vialogy had a high tech product which wasn't taken up by the market. However, the news flow always seemed to be positive. Is history beginning to repeat itself here?
Hargreaves Lansdown and ETX Capital. I assume others out there with these two, are yet to hear from them? TIA
What will happen to my existing shares if I don't take up the offer? And has anyone with barclays heard anything about an open offer yet?
You may not have the funds to purchase your FULL entitlement but you can (I believe) elect to take up whatever PART of your entitlement that you can afford. Then what you do not take up will go into a pool of such un-excercised entitlements which will then be distributed amongst the applicants who have asked for more than their entitlement. Just ask your broker.
Yes ive been offered 46,000 shares to buy @ 11p _ approx £4.5k's worth
Yeah think I may have made that one up! I've just taken up the open offer so it will be interesting to see if I get any extras or not.
Thanks for that info - commercialisation, nice long word. jony jackles - as we've passed the record date, I reckon you could sell all your shares now and still have your Open Offer entitlement - but why not ask your broker.
I'll add this again re competition - "The technology used in the IONA® Test will be new to many potential customers."
First one in UK and Europe as far as I understood, the other one is licensed in the States.